| [1] |
Tian LT, Yao K, Zhang XY, et al. Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clin Microbiol Infect, 2012, 18: E314-30.
|
| [2] |
Li W, Chen H, Wu S, et al. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol, 2018, 18: 144.
|
| [3] |
Lai SW, Lin CL, Liao KF. Predialysis chronic kidney disease correlates with increased risk of pyogenic liver abscess: a population-based cohort study. Eur J Clin Invest, 2017, 47: 694-701.
|
| [4] |
Liao KF, Cheng KC, Lin CL, et al. Statin use correlates with reduced risk of pyogenic liver abscess: a population-based case-control study. Basic Clin Pharmacol Toxicol, 2017, 121: 144-149.
|
| [5] |
Lin HF, Liao KF, Chang CM, et al. Correlation between proton pump inhibitors and risk of pyogenic liver abscess. Eur J Clin Pharmacol, 2017, 73: 1019-1025.
|
| [6] |
Shi SH, Zhai ZL, Zheng SS. Pyogenic liver abscess of biliary origin: the existing problems and their strategies. Semin Liver Dis, 2018, 38: 270-283.
|
| [7] |
Czerwonko ME, Huespe P, Elizondo CM, et al. Risk factors and outcomes of pyogenic liver abscess in adult liver recipients: a matched case-control study. HPB (Oxford), 2018, 20: 583-590.
|
| [8] |
Shin JU, Kim KM, Shin SW, et al. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis, 2014, 46: 813-817.
|
| [9] |
Kesar V, Swaminath A. Hepatic masses in a patient with inflammatory bowel disease. Gastroenterology, 2018, 154: e5-e6.
|
| [10] |
Sivarajah SS, Shahzard S, Chew MH. Unusual cause of liver abscess. Gastroenterology, 2018, 155: e7-e8.
|
| [11] |
Czerwonko ME, Huespe P, Bertone S, et al. Pyogenic liver abscess: current status and predictive factors for recurrence and mortality of first episodes. HPB (Oxford), 2016, 18: 1023-1030.
|
| [12] |
Luo M, Yang XX, Tan B, et al. Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis. Eur J Clin Microbiol Infect Dis, 2016, 35: 1557-1565.
|
| [13] |
Chen N, Ling ZX, Jin TT, et al. Altered profiles of gut microbiota in klebsiella pneumoniae-induced pyogenic liver abscess. Curr Microbiol, 2018, 75: 952-959.
|
| [14] |
Siu LK, Yeh KM, Lin JC, et al. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect Dis, 2012, 12: 881-887.
|
| [15] |
Shi SH, Feng XN, Lai MC, et al. Biliary diseases as main causes of pyogenic liver abscess caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae. Liver Int, 2017, 37: 727-734.
|
| [16] |
Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis, 2013, 13: 785-796.
|
| [17] |
Sanford JP. The Sanford guide to antimicrobial therapy 2016 46th ed. Antimicrobial Therapy Inc,2016: 114-115.
|
| [18] |
Cai YL, Xiong XZ, Lu J, et al. Percutaneous needle aspiration versus catheter drainage in the management of liver abscess: a systematic review and meta-analysis. HPB (Oxford), 2015, 17: 195-201.
|
| [19] |
Lai HC, Lin CC, Cheng KS, et al. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study. Gastroenterology, 2014, 146: 129-137 e1.
|
| [20] |
Wang JL, Dong YH, Ko WC, et al. Thiazolidinediones and reduced risk of incident bacterial abscess in adults with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab, 2018, 20: 2811-2820.
|
